COST-UTILITY ANALYSIS OF VALSARTAN VERSUS VALSARTAN PLUS HYDROCHLOROTHIAZIDE IN PATIENTS WITH HYPERTENSION IN THE US

被引：0

作者：

Pednekar, P. ^{[1
]}

机构：

[1] Univ Sci, Philadelphia, PA USA

来源：

VALUE IN HEALTH | 2018年 / 21卷

关键词：

D O I：

10.1016/j.jval.2018.04.374

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PCV52

引用

页码：S62 / S62

页数：1

共 50 条

[31] Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with Stage 2 hypertension
Flack, John M.
Yadao, Anthony M.
Purkayastha, Das
Samuel, Rita
White, William B.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2012, 6 (02) : 142 - 151
[32] Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study
Sison, Jorge
Assaad-Khalil, Samir Helmy
Najem, Robert
Kitchlew, Asad Riaz
Cho, Belong
Ueng, Kwo-Chang
Shete, Abhijit
Knap, Ditte
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (10) : 1937 - 1945
[33] TRIPLE COMBINATION OF VALSARTAN, AMLODIPINE, AND HCTZ PROVIDES EFFECTIVE REDUCTION OF BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION NOT CONTROLLED BY DUAL THERAPY WITH AMLODIPINE PLUS VALSARTAN OR VALSARTAN PLUS HCTZ
Braun, N.
Handrock, R.
Klebs, S.
Schweizer, J.
JOURNAL OF HYPERTENSION, 2009, 27 : S272 - S273
[34] Amlodipine/Valsartan/Hydrochlorothiazide Fixed-Dose Combination in Hypertension
Deeks, Emma D.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (06) : 411 - 418
[35] Patient compliance and persistence with combination valsartan/hydrochlorothiazide therapy versus hydrochlorothiazide therapy
Nguyen, AB
Plauschinat, CA
Frech, FF
Gause, D
Zhang, W
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 120A - 120A
[36] Patient compliance and persistency with combination valsartan/hydrochlorothiazide therapy versus hydrochlorothiazide therapy
Plauschinat, CA
Nguyen, AB
Frech, FH
Gause, D
Zhang, W
JOURNAL OF HYPERTENSION, 2004, 22 : S258 - S258
[37] Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
Arya M Sharma
Jaime Davidson
Stephen Koval
Yves Lacourcière
Cardiovascular Diabetology, 6
[38] Telmisartan/Hydrochlorothiazide versus Valsartan/Hydrochlorothiazide in Obese Hypertensive Patients with Type 2 Diabetes: the SMOOTH Study
Hoefler-Speckner, Simone
JOURNAL FUR HYPERTONIE, 2007, 11 (04):
[39] Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes:: the SMOOTH study
Sharma, Arya M.
Davidson, Jaime
Koval, Stephen
Lacourciere, Yves
CARDIOVASCULAR DIABETOLOGY, 2007, 6 (1)
[40] HYPERTENSION ASSOCIATED VASCULAR INFLAMMATION IN AFRICAN AMERICANS: EFFECTS OF COMBINING VALSARTAN WITH HYDROCHLOROTHIAZIDE VERSUS AMLODIPINE
Robinson, A. D.
Daley, W.
Zappe, D.
Jamerson, K.
ETHNICITY & DISEASE, 2008, 18 (03) : S32 - S32

← 1 2 3 4 5 →